Skip to content

GRFS

Grifols SA

NASDAQ · Healthcare · Drug Manufacturers - General · ES

$8.07
+0.31%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
20.85x
P/E 2026E
8.38x
P/E 2027E
6.63x
P/E 2028E
5.15x
P/S forward
0.91x

Trailing multiples

Trailing twelve months

P/E TTM
10.77x
PEG TTM
0.48x
Price / book
0.89x
Price / sales
0.66x
Price / cash flow
4.48x

Enterprise value

Enterprise value
$17.1B
EV / sales
2.06x
EV / EBITDA
8.76x
EV / EBIT
12.39x
Market cap
$5.5B

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026